Qureator

Qureator is a groundbreaking company at the forefront of biotechnology research, transforming drug discovery and development through a revolutionary AI-powered human biology platform. Located in San Diego, California, with additional offices in Seoul, South Korea, Qureator addresses the critical challenges of traditional drug discovery models, which often struggle to accurately replicate human biology, leading to costly inefficiencies and high failure rates. The company's innovative approach integrates Next-Generation Microphysiological Systems (MPS) technology with cutting-edge AI solutions, providing a human biology-based platform that faithfully mimics complex disease phenotypes and patient-specific responses.

At the core of Qureator’s platform are its two key technologies: Curiochips and Quricore. Curiochips enables the integration of patient-derived cells into physiologically relevant, high-throughput models, ensuring more accurate disease replication and drug testing. Quricore, a sophisticated AI-powered analytical engine, accelerates research by generating rapid, high-precision hypotheses and facilitating data-driven decision-making. This powerful combination significantly reduces the time and cost associated with traditional preclinical testing, accelerating the journey to vital new therapies.

Qureator is committed to revolutionizing the drug discovery process and empowering researchers with the tools needed to bring transformative medicines to patients. The company’s advanced computational modeling and predictive analytics enhance explainability and ensure robust insights, providing unprecedented visibility into drug efficacy and toxicity. Qureator’s headquarters are located at 7094 Miratech Dr, Suite 110, San Diego, California 92121, US, with an additional address at 3F, 159, Bongeunsa-ro, Gangnam-gu, Seoul, 06122, KR. We invite our manager to explore the possibilities of a customized and exclusive company showcase and product listing on our platform to further amplify Qureator’s reach and impact.